Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Clinical Trial Updates
Page 24
Clinical Trial Updates
Clinical trial updates
Study: Isatuximab Combination Provides Unprecedented Median PFS in Treatment of Multiple Myeloma
Peter Hofland, Ph.D
-
May 15, 2022
ALL Patients With Certain Gene Regulation Patterns May Be Less Likely to Respond to CAR T Therapy
First Pateint Dosed with Allogeneic, off-the-shelf, Invariant Natural Killer T-cell Therapy
Pembrolizumab Shows Significantly Prolonged Event-free Survival in High-Risk Early-Stage TNBC
Why Taking a Less Personalized Approach May Increase Access to Cancer Care for Elderly Patients
Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) Shows Prolonged Progression Free...
Shaun Mehr, Associate Publisher
-
December 11, 2012
New CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Anti-tumor Activity in...
Shaun Mehr, Associate Publisher
-
December 11, 2012
Long-term Phase III Data Show Ph+ CML Patients Treated with Nilotinib...
Shaun Mehr, Associate Publisher
-
December 10, 2012
Trial Results of Quizartinib in Patients with Relapsed and Refractory AML...
Shaun Mehr, Associate Publisher
-
December 10, 2012
Targeted Molecular Therapy for Untreatable Neurofibromatosis 1 (NF1) Tumors Identified
Shaun Mehr, Associate Publisher
-
December 10, 2012
Sanofi's Selective JAK2 inhibitor (SAR302503) Meets Primary Endpoint in Phase II...
Shaun Mehr, Associate Publisher
-
December 10, 2012
Majority of Pediatric Patients with Hodgkin Lymphoma Achieve CR After Treatment...
Peter Hofland, Ph.D
-
September 24, 2011
Novel Regimen Boosts Event-Free Survival in Children and Young Adults With...
Shaun Mehr, Associate Publisher
-
June 5, 2011
Vemurafenib Improves Overall Survival in Advanced Melanoma
Shaun Mehr, Associate Publisher
-
June 5, 2011
New Regimen with High-Dose Chemotherapy Improves Survival Hard-to-Treat Pediatric Neuroblastoma
Shaun Mehr, Associate Publisher
-
June 5, 2011
1
...
23
24
25
Page 24 of 25
LATEST NEWS
Combating Financial Hurdles: Setting up Physicians for Short- and Long-term Financial Success
Charlie Nemes
-
May 18, 2022
Researchers Identify a New Subset of High-risk Pediatric Liver Cancer
Peter Hofland, Ph.D
-
May 17, 2022
Polypharmacy – How Cancer Patients Face Higher Risks of Drug Interactions
Leslie Orr
-
May 16, 2022
Study: Isatuximab Combination Provides Unprecedented Median PFS in Treatment of Multiple Myeloma
Peter Hofland, Ph.D
-
May 15, 2022
Bioimpedance Spectroscopy Better than Tape Measure for Preventing Breast Cancer-Related Lymphedema
Sheila Ridner, PhD, RN, FAAN
-
May 13, 2022
X